Pharmacogenomics, ethics, and public policy. Export

@article{citeulike:4734176, abstract = {The advent of pharmacogenomics--the study of how the human genome influences drug response within a person or population--has begun to drive the development of pharmaceuticals in Western medicine today. Although pharmacogenomics promises dramatic improvement in drug safety and efficacy, the field also raises a host of ethical questions. The need to protect informed consent and confidentiality and to promote justice and equity--both nationally and globally--requires that one approach pharmacogenomics with an enthusiastic, yet critical, eye. Drawing on the normative values of respect for persons (as both autonomous and relational), human well-being, socioeconomic justice, and human solidarity and the common good, this article offers several concrete suggestions for public policy to help ensure that pharmacogenomics develops in a way that promotes the good of both individuals and the broader society.}, author = {Peterson-Iyer, K.}, citeulike-article-id = {4734176}, citeulike-linkout-0 = {http://view.ncbi.nlm.nih.gov/pubmed/18561577}, citeulike-linkout-1 = {http://www.hubmed.org/display.cgi?uids=18561577}, issn = {1054-6863}, journal = {Kennedy Institute of Ethics journal}, keywords = {elsi, personalized-medicine, pharmacogenomics, policy}, month = {March}, number = {1}, pages = {35--56}, posted-at = {2009-06-03 16:21:44}, priority = {2}, title = {Pharmacogenomics, ethics, and public policy.}, url = {http://view.ncbi.nlm.nih.gov/pubmed/18561577}, volume = {18}, year = {2008} }

TY - JOUR ID - citeulike:4734176 L3 - citeulike-article-id:4734176 N2 - The advent of pharmacogenomics--the study of how the human genome influences drug response within a person or population--has begun to drive the development of pharmaceuticals in Western medicine today. Although pharmacogenomics promises dramatic improvement in drug safety and efficacy, the field also raises a host of ethical questions. The need to protect informed consent and confidentiality and to promote justice and equity--both nationally and globally--requires that one approach pharmacogenomics with an enthusiastic, yet critical, eye. Drawing on the normative values of respect for persons (as both autonomous and relational), human well-being, socioeconomic justice, and human solidarity and the common good, this article offers several concrete suggestions for public policy to help ensure that pharmacogenomics develops in a way that promotes the good of both individuals and the broader society. IS - 1 JF - Kennedy Institute of Ethics journal SN - 1054-6863 EP - 56 TI - Pharmacogenomics, ethics, and public policy. VL - 18 SP - 35 KW - elsi KW - personalized-medicine KW - pharmacogenomics KW - policy AU - Peterson-Iyer, K PY - 2008/03// UR - http://view.ncbi.nlm.nih.gov/pubmed/18561577 ER -